No treatment reaches patients without first demonstrating, in controlled stages, that it is safe and effective.
Clinical trials are the foundation of modern medical development. They evaluate the safety and efficacy of new drugs, devices and therapies before they are approved for use, and they remain the main mechanism for validating health innovation.
Safety
Before a new treatment is approved, researchers run trials in successive phases. These stages identify adverse effects and establish safe conditions of use, so that the benefits outweigh the risks.
Proven efficacy
Beyond safety, trials assess whether the treatment works. Controlled trials compare new options with existing treatments or placebo and measure outcomes with statistical rigor.
Personalized medicine
Personalized medicine, which tailors treatment to each patient's profile, depends on studies designed to identify which therapies work best in each group.
Vaccines and new therapies
Clinical trials were decisive in the development of COVID-19 vaccines and remain essential for vaccines and therapies targeting other diseases.
Before the clinic: the preclinical foundation
A clinical trial only begins after a consistent preclinical stage. For drugs, devices and biomaterials, that includes physicochemical characterization of the materials, purity control and batch-to-batch reproducibility, as well as laboratory safety and performance testing.
The better documented that foundation, the more solid the regulatory path. This is the stage where Triplet works, with physicochemical characterization and the development of materials such as hydroxyapatite, supplied as a technical input for research and development.
Conclusion
Clinical trials turn hypotheses into safe, effective treatments. Each stage depends on the one before it, and the quality of the materials and data generated before the clinic is a decisive part of that path.
